Data / Form D filings / Pulse Therapeutics, Inc.
Pulse Therapeutics, Inc.: Form D filings
Pulse Therapeutics, Inc., a biotechnology company in St. Louis, MO, filed 5 Form D notices with the SEC between 2011 and 2016. The latest, on January 27, 2016, reports $5.6 million sold of a $13.8 million offering to 29 investors.
Find out what Pulse Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 911 WASHINGTON AVENUE, SUITE 730, St. Louis, MO, 63101
- Phone
- (314) 787-7475
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1518707
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2016 | New notice | $13,754,074 | $5,615,708 | $8,138,366 | 29 | Jan 12, 2016 | sec.gov |
| Feb 6, 2014 | New notice | $1,500,000 | $1,025,000 | $475,000 | 3 | Dec 23, 2013 | sec.gov |
| Dec 30, 2011 | New notice | $3,090,000 | $3,090,000 | $0 | 4 | Dec 15, 2011 | sec.gov |
| Aug 1, 2011 | Amendment | $2,000,000 | $1,650,000 | $350,000 | 8 | Apr 6, 2011 | sec.gov |
| Apr 21, 2011 | New notice | $2,000,000 | $1,325,000 | $675,000 | 5 | Apr 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PEGGY STOHR | Executive Officer | |
| SEAN MORRIS | Executive Officer, Director | |
| THOMAS HILLMAN | Director | |
| ERIC MOESSINGER | Director |
Every Form D from the week of Jan 25, 2016 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pulse Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.